Progesterone-receptor positive breast cancer
MONDO:00006153427 clinical trials for this condition and its sub-types, 16 tagged with Progesterone-receptor positive breast cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Progesterone-receptor positive breast cancer
-
Hormone receptor-positive breast cancer 633 trials
-
Triple-positive breast carcinoma 33 trials
-
Promising combo for rare breast cancer subtype hits early snag
Disease control Stopped earlyThis early-phase trial tested a combination of two drugs—infigratinib (a targeted therapy) and tamoxifen (a hormone therapy)—in people with a specific type of advanced breast cancer (hormone receptor-positive, HER2-negative, with FGFR gene changes). The goal was to find a safe do…
Phase 1 • Sponsor: Jennifer Lee Caswell-Jin • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Cancer drug trial halted midway: what happened?
Disease control Stopped earlyThis study tested an experimental drug called VLS-101 in 102 people with advanced solid tumors, including breast, lung, ovarian, stomach, and pancreatic cancers that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors. However, the t…
Phase 2 • Sponsor: VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill targets Hard-to-Treat cancers in early human test
Disease control Stopped earlyThis early-phase trial tested an experimental oral drug called NKT3447 in 23 adults with advanced or metastatic solid tumors that had stopped responding to standard treatments. The goal was to check safety, find the right dose, and see if the drug could shrink tumors. The study w…
Phase 1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC